Bioterrorism
U.S. NIH awards $4.6 million challenge grant for R&D of intranasal anthrax vaccine
Published in Medical Letter on the CDC and FDA, November 6th, 2005
"Securing this level of a competitive NIH award validates our anthrax vaccine approach and allows us to quickly move forward in our preclinical development," said Dr. Charles Richardson, LigoCyte senior VP of research and development.
LigoCyte's vaccine programs, aimed against potential agents of biowarfare, continue to be funded by the U.S. Department of Defense (DOD) through appropriations supported by Senator Conrad Burns (R-MT).
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Hemophilia Therapy
Republic of Georgia develops successful national hemophilia program - Measles Vaccine
Measles control program reduces measles deaths by 20% in Africa - Natural Products
Russian ethnomedicinal plants more cytotoxic than established therapies - Neural Tube Defects
Prevalence of spina bifida and anencephaly declining in U.S. minorities - Sexually Transmitted Diseases
Phone call more cost-effective than counseling for prompting follow-up clinic visits - Adverse Drug Reaction
Agencies issue alert on Menactra meningococcal vaccine and Guillain Barre syndrome - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
